Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 34 (2013), Issue 2, Pages 113-120
http://dx.doi.org/10.3233/DMA-120949

Novel ERBB Receptor Feedback Inhibitor 1 (ERRFI1) + 808 T/G Polymorphism Confers Protective Effect on Diabetic Nephropathy in a Korean Population

Ihn Suk Lee,1 Ju Hee Lee,2 Hyun Jin Kim,2 Jae Min Lee,3 Seong Kyu Lee,3 Hye Soo Kim,1 Jong Min Lee,1 Kang Seo Park,3 and Bon Jeong Ku2,4

1Department of Internal Medicine, The Catholic University College of Medicine, Daejeon, Korea
2Department of Internal Medicine, Chungnam National University School of Medicine, Daejeon, Korea
3Department of Internal Medicine, Eulji University School of Medicine, Daejeon, Korea
4Research Institute for Medical Sciences, Chungnam National University School of Medicine, Daejeon, Korea

Received 24 December 2012; Accepted 24 December 2012

Copyright © 2013 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Ihn Suk Lee, Ju Hee Lee, Hyun Jin Kim, et al., “Novel ERBB Receptor Feedback Inhibitor 1 (ERRFI1) + 808 T/G Polymorphism Confers Protective Effect on Diabetic Nephropathy in a Korean Population,” Disease Markers, vol. 34, no. 2, pp. 113-120, 2013. doi:10.3233/DMA-120949